TCF19 and nonpapillary renal cell carcinoma: Remarkably, FOXM1 binding to the CoBs was significantly reduced upon TCF19‐KD treatment (Figure S11C), whereas FOXM1‐KD did not affect the affinity of TCF19 binding at the CoB locus in ccRCC cells (Figure S11D).